Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
63.2M
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
26.1M
-
Shares change
-
+2.98M
-
Total reported value, excl. options
-
$576M
-
Value change
-
+$73.5M
-
Number of buys
-
55
-
Number of sells
-
-33
-
Price
-
$22.07
Significant Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q3 2022
105 filings reported holding TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value as of Q3 2022.
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.1M shares
of 63.2M outstanding shares and own 41.27% of the company stock.
Largest 10 shareholders include ALLIANCEBERNSTEIN L.P. (3.26M shares), VANGUARD GROUP INC (3.22M shares), BlackRock Inc. (2.27M shares), PERCEPTIVE ADVISORS LLC (1.6M shares), NEXT CENTURY GROWTH INVESTORS LLC (1.58M shares), CIBC Private Wealth Group, LLC (1.14M shares), EMERALD ADVISERS, LLC (1.12M shares), TimesSquare Capital Management, LLC (1.01M shares), EMERALD MUTUAL FUND ADVISERS TRUST (912K shares), and DRIEHAUS CAPITAL MANAGEMENT LLC (709K shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.